Vaccine Slows Recurrence in Skin Cancer....
In what researchers are calling a first, a vaccine that targets skin cancer cells shrinks tumors and cuts the chance that the disease will return.
In what researchers are calling a first, a vaccine that targets skin cancer cells shrinks tumors and cuts the chance that the disease will return. (ABC News Photo Illustration)In a large clinical trial, more than twice as many people who got the vaccine saw their tumors shrink compared to those who didn't get the drug, Dr. Douglas Schwartzentruber of Indiana University told colleagues at the annual meeting of the American Society of Clinical Oncology.
The study is "one of the first to show positive, promising results for a cancer vaccine" to fight the often-deadly skin cancer melanoma, Schwartzentruber said.
When it spreads from its original site, melanoma is difficult to treat and resistant to most therapies, he said. "These results will give patients and the oncology community hope that we are making some progress against this disease," Schwartzentruber said